Multicenter Myocardial Viability Trial

Completed

Conditions studied: Coronary Artery Disease

In brief

The purpose of this study is to test the hypothesis of whether contrast enhanced Magnetic Resonance Imaging can be used to predict improvement of the wall motion in regions of the heart with abnormal movement following bypass surgery or percutaneous angioplasty in various institutions across three continents.

Key facts

Study ID

NCT00661232

Run by

CHI St. Luke's Health, Texas

People needed

235

Starts

2003-08-11

Expected to finish

2011-05-15

Last updated by the study team

2020-12-02

Who can join

Age: 21 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age: > 21 years and < 85 years
• Sinus rhythm
• Weight < 120 kg
• LVEF > 30%
• Wall motion abnormality on Echo. or LV-gram
• Scheduled for revascularization - Angioplasty/Stent or CABG - within 30 days

You may not qualify if…

• Resting heart rate > 100 bpm
• Frequent atrial or ventricular ectopy
• Severe aortic stenosis or HOCM
• Unstable angina
• Myocardial infarction within 14 days
• Active congestive heart failure
• Pregnancy
• Known allergy to gadolinium
• Contraindication to MRI

Where it is running

• St. Luke's Episcopal Hospital — Houston, Texas, United States
• St. Luke's Episcopal Location — Houston, Texas, United States
• Cliniques Universitaires St. Luc — Brussels, Belgium
• Skejby University Hospital — Aarhus N, Denmark
• Hygeia Hospital — Marousi, Greece
• Siriraj Hospital — Bangkoknoi, Bangkok, Thailand
• Cardiac MRI Unit — Leeds, United Kingdom

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.